AVE reference standards and related compounds are essential tools for the analytical investigation of Aveipimod, a selective serotonin and dopamine reuptake inhibitor developed as a dual-mechanism antidepressant… Read more
AVE reference standards and related compounds are essential tools for the analytical investigation of Aveipimod, a selective serotonin and dopamine reuptake inhibitor developed as a dual-mechanism antidepressant for treating major depressive disorder. By inhibiting the presynaptic reuptake of these neurotransmitters, the drug increases their availability within the synaptic cleft to help manage depressive symptoms. To support the rigorous quality control and method validation required for this pharmaceutical, laboratories utilize high-quality AVE-0118 impurities and stable isotope labelled standards. These compounds are critical for accurate impurity profiling and quantitative analysis in mass spectrometry applications, ensuring that analytical methods remain precise during regulatory testing and developmental phases. Accessing these well-characterized reference materials allows researchers to reliably identify and quantify trace-level substances, maintaining compliance with safety and efficacy standards throughout the drug development lifecycle.